Rankings
▼
Calendar
AVBP FY 2021 Earnings — ArriVent BioPharma, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$52M
EPS (Diluted)
$-40.44
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$43M
Total Liabilities
$2M
Stockholders' Equity
$41M
Cash & Equivalents
$37M
← Q1 2022
All Quarters
